| Top ten biotechnologies for improving health in developing countries AS Daar, H Thorsteinsdóttir, DK Martin, AC Smith, S Nast, PA Singer Nature genetics 32 (2), 229-232, 2002 | 474 | 2002 |
| Regenerative medicine and the developing world HL Greenwood, PA Singer, GP Downey, DK Martin, H Thorsteinsdottir, ... PLoS medicine 3 (9), e381, 2006 | 128 | 2006 |
| External research collaboration in two small science systems OH Thorsteinsdottir Scientometrics 49, 145-160, 2000 | 111 | 2000 |
| Cuba—innovation through synergy H Thorsteinsdóttir, TW Sáenz, U Quach, AS Daar, PA Singer Nature biotechnology 22 (Suppl 12), DC19-DC24, 2004 | 99 | 2004 |
| Regenerative medicine: new opportunities for developing countries HL Greenwood, H Thorsteinsdóttir, G Perry, J Renihan, P Singer, A Daar International journal of biotechnology 8 (1-2), 60-77, 2006 | 98 | 2006 |
| Conclusions: promoting biotechnology innovation in developing countries H Thorsteinsdóttir, U Quach, AS Daar, PA Singer Nature Biotechnology 22 (Suppl 12), DC48-DC52, 2004 | 95 | 2004 |
| Indian biotechnology—rapidly evolving and industry led NK Kumar, U Quach, H Thorsteinsdóttir, H Somsekhar, AS Daar, ... Nature biotechnology 22 (Suppl 12), DC31-DC36, 2004 | 82 | 2004 |
| The scientific muscle of Brazil's health biotechnology M Ferrer, H Thorsteinsdóttir, U Quach, PA Singer, AS Daar Nature Biotechnology 22 (Suppl 12), DC8-DC12, 2004 | 76 | 2004 |
| Health biotechnology in China—reawakening of a giant L Zhenzhen, Z Jiuchun, W Ke, H Thorsteinsdóttir, U Quach, PA Singer, ... Nature Biotechnology 22 (Suppl 12), DC13-DC18, 2004 | 73 | 2004 |
| Priority setting for orphan drugs: an international comparison ZRS Rosenberg-Yunger, AS Daar, H Thorsteinsdóttir, DK Martin Health Policy 100 (1), 25-34, 2011 | 68 | 2011 |
| Cultivating regenerative medicine innovation in China DS McMahon, H Thorsteinsdóttir, PA Singer, AS Daar Regenerative Medicine 5 (1), 35-44, 2010 | 61 | 2010 |
| Pursuing endogenous high-tech innovation in developing countries: A look at regenerative medicine innovation in Brazil, China and India D McMahon, H Thorsteinsdóttir Research Policy 42 (4), 965-974, 2013 | 60 | 2013 |
| South-South entrepreneurial collaboration in health biotech H Thorsteinsdóttir, CC Melon, M Ray, S Chakkalackal, M Li, JE Cooper, ... Nature biotechnology 28 (5), 407-416, 2010 | 59 | 2010 |
| South Korean biotechnology—a rising industrial and scientific powerhouse J Wong, U Quach, H Thorsteinsdóttir, PA Singer, AS Daar Nature Biotechnology 22 (Suppl 12), DC42-DC47, 2004 | 58 | 2004 |
| South Africa—blazing a trail for African biotechnology M Motari, U Quach, H Thorsteinsdóttir, DK Martin, AS Daar, PA Singer Nature biotechnology 22 (Suppl 12), DC37-DC41, 2004 | 50 | 2004 |
| Introduction: promoting global health through biotechnology H Thorsteinsdóttir, U Quach, DK Martin, AS Daar, PA Singer Nature biotechnology 22 (Suppl 12), DC3-DC7, 2004 | 47 | 2004 |
| Genomics knowledge and equity: a global public goods perspective of the patent system RD Smith, H Thorsteinsdóttir, AS Daar, ER Gold, PA Singer Bulletin of the World Health Organization 82 (5), 385-389, 2004 | 42 | 2004 |
| Harnessing stem cells for health needs in India B Lander, H Thorsteinsdottir, PA Singer, AS Daar Cell Stem Cell 3 (1), 11-15, 2008 | 40 | 2008 |
| The role of the health system in health biotechnology in developing countries H Thorsteinsdóttir Technology Analysis & Strategic Management 19 (5), 659-675, 2007 | 39 | 2007 |
| Genomics—a global public good? H Thorsteinsdóttir, AS Daar, RD Smith, PA Singer The Lancet 361 (9361), 891-892, 2003 | 39 | 2003 |
Professor Sachin ChaturvediResearch and Information System for Developing Countries, RIS確認したメール アドレス: ris.org.in
